Edinburgh, United Kingdom

Jordi Juarez-Jimenez

This inventor holds 1 USPTO granted patent. Top assignee: The University of Edinburgh. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jordi Juarez-Jimenez. Retrieved from https://idiyas.com/inventor/jordi-juarez-jimenez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jordi Juarez-Jimenez

Introduction

Jordi Juarez-Jimenez is a notable inventor based in Edinburgh, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of cyclophilins function. His work has implications for the treatment of various disorders, showcasing the importance of innovation in medical research.

Latest Patents

Jordi holds a patent for "Compounds for the modulation of cyclophilins function." This invention relates to compounds of formula (I) or a pharmaceutically acceptable salt thereof, which are useful as inhibitors of Cyclophilins and modulators of cyclophilin-like proteins. The patent outlines various chemical structures and their potential applications in treating different medical conditions.

Career Highlights

Jordi is affiliated with The University of Edinburgh, where he conducts research and develops innovative solutions in his field. His work is characterized by a commitment to advancing scientific knowledge and improving health outcomes through targeted therapies.

Collaborations

Some of his notable coworkers include Charis Georgiou and Alessio De Simone. Their collaborative efforts contribute to the ongoing research and development initiatives at the university.

Conclusion

Jordi Juarez-Jimenez exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and research are paving the way for new treatments and advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…